Tifcemalimab JS004
| 产品介绍 | Tifcemalimab (JS004) 是一种人源化抗 BTLA (B和T淋巴细胞衰减因子) 单克隆抗体。Tifcemalimab 通过与 BTLA 结合，阻断 HVEM-BTLA 的相互作用，从而阻断 BTLA 介导的抑制信号通路。Tifcemalimab 可用于癌症的研究。 |
|---|---|
| 生物活性 | Tifcemalimab (JS004) is a humanized anti-BTLA (B and T lymphocyte attenuation factor) monoclonal antibody. Tifcemalimab blocks the interaction of HVEM-BTLA by binding to BTLA, and thus blocks the inhibitory signaling pathway mediated by BTLA. Tifcemalimab can be used in research of cancer. |
| 体外研究 | |
| 体内研究 | |
| 体内研究 | |
| 性状 | Liquid |
| 溶解性数据 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis. |
| 参考文献 |
浙公网安备 33010802013016号